No, not all skin cancer is melanoma. Melanoma is actually the least common of the three main types of skin cancer. The other two, basal cell carcinoma and squamous cell carcinoma, account for the vast majority of skin cancer diagnoses each year. Understanding the differences matters because these cancers look different on the skin, grow at different speeds, and require different levels of concern.
The Three Main Types of Skin Cancer
Skin cancer falls into three primary categories: basal cell carcinoma, squamous cell carcinoma, and melanoma. Basal cell carcinoma is the most common by a wide margin, followed by squamous cell carcinoma. Melanoma is much less common than either of these but is far more likely to invade nearby tissue and spread to other parts of the body. That’s why melanoma gets the most attention and carries the most fear, even though it represents a small fraction of total skin cancer cases.
There are also rarer forms of skin cancer beyond these three. Merkel cell carcinoma, for instance, is an uncommon but aggressive cancer that typically appears as a bump on the face, head, or neck, most often in people over 50. It tends to grow and spread quickly. A common virus that lives on the skin, called Merkel cell polyomavirus, plays a role in causing it.
What Basal Cell Carcinoma Looks Like
Basal cell carcinoma usually shows up on parts of the body that get the most sun, especially the head and neck. It appears as a change in the skin: a growth or a sore that won’t heal. On lighter skin, it often looks like a slightly transparent, pearly white or pink bump. On brown and Black skin, it tends to appear as a brown or glossy black bump with a rolled border. Tiny blood vessels may be visible on the surface.
It doesn’t always look like a bump, though. Basal cell carcinoma can also appear as a flat, scaly patch that grows larger over time, a brown or blue lesion with dark spots and a slightly raised border, or a white, waxy, scarlike area without a clearly defined edge. These variations make it easy to dismiss as a minor skin irritation, which is why growths that don’t heal deserve a closer look.
How Squamous Cell Carcinoma Differs
Squamous cell carcinoma is the second most common type. Like basal cell carcinoma, it tends to develop on sun-exposed areas: the ears, face, neck, and forearms. It often appears as a firm, red nodule or a flat lesion with a scaly, crusted surface. While it’s more likely to spread than basal cell carcinoma, it still carries a much better outlook than melanoma when caught early. Both basal cell and squamous cell carcinomas are sometimes grouped together under the label “non-melanoma skin cancer.”
Why Melanoma Is More Dangerous
Melanoma develops in the cells that give your skin its color. What sets it apart from other skin cancers is its tendency to spread. When melanoma is caught early and remains localized to the skin, the five-year survival rate is 97.6%. But if it reaches nearby lymph nodes, that rate drops to 60.3%. Once it has spread to distant organs, it falls to 16.2%. The good news is that roughly 83% of melanomas are diagnosed at the localized stage, when treatment is most effective.
Melanoma can appear anywhere on the body, not just sun-exposed areas. It often shows up as a new, unusual-looking mole or a change in an existing mole. Irregular borders, multiple colors within the same spot, asymmetry, and a diameter larger than a pencil eraser are classic warning signs.
Different UV Patterns, Different Cancers
The relationship between sun exposure and skin cancer isn’t one-size-fits-all. Non-melanoma skin cancers are strongly linked to long-term, repeated UV exposure over the course of your life. The fact that they cluster on chronically sun-exposed areas like the face, ears, and forearms supports this connection.
Melanoma, on the other hand, is more closely tied to intense, intermittent sun exposure. Several studies have found a strong association between a history of sunburns, particularly sunburns during childhood, and later melanoma risk. This helps explain why melanoma can appear on parts of the body that aren’t regularly exposed to the sun: it’s not just about total lifetime UV dose but about those acute, damaging episodes of overexposure. That said, people who have had non-melanoma skin cancers do face a higher risk of melanoma as well, since both reflect significant UV damage over time.
How Doctors Tell Them Apart
A biopsy is the only definitive way to determine what type of skin cancer you’re dealing with. The type of biopsy depends on what your doctor suspects. If basal cell or squamous cell carcinoma seems likely, a punch or shave biopsy is typically sufficient. These involve removing a small sample of tissue for examination. If melanoma is a possibility, doctors usually perform an excisional biopsy, removing the entire suspicious area to make sure all of the abnormal tissue is captured and can be properly evaluated.
Treatment Varies by Type
Because non-melanoma skin cancers are typically slower growing and less likely to spread, they offer a wider range of treatment options. Surgery is the most common approach, but when the cancer covers a large area, sits in a difficult location, or has spread to lymph nodes, radiation therapy may be recommended. For very superficial cancers that affect only the top layer of skin, a chemotherapy cream applied for three to four weeks can be effective. Photodynamic therapy, which uses a light-sensitive medication activated by a targeted light source, is another option for thin, non-spreading cancers.
For more advanced non-melanoma cases where the cancer has reached deeper layers or spread to other parts of the body, targeted medicines or immunotherapy may be used. These come in various forms: skin creams, tablets, or infusions. Targeted therapies work by blocking the cancer’s ability to grow, while immunotherapy helps your immune system recognize and attack cancer cells.
Melanoma treatment depends heavily on the stage at diagnosis. Early-stage melanoma is often treated with surgery alone. More advanced melanoma may require immunotherapy, targeted therapy, or radiation. The stakes are higher because of melanoma’s tendency to spread, which is why early detection makes such a dramatic difference in outcomes.